Journal of Neuroscience · 2001 · 271 citations · 33 references
Life SciencesNeurobiologyNeuroscienceInflammationNeuroimmunologySignal TransductionAlzheimer DiseaseG Protein-coupled Receptor SignalingMicroglia BiologyNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationAlzheimer Disease NeuroimmunologyAmyloid Beta PeptidesAmyloid Beta PlaquesChemotactic MediatorsChemotactic SignalingNeuroinflammation In Alzheimer DiseaseTherapeutic Targeting Of AmyloidTissue Infiltration By Inflammatory Cells
Amyloid beta (Abeta) is a major contributor to the pathogenesis of Alzheimer's disease (AD). Although Abeta has been reported to be directly neurotoxic, it also causes indirect neuronal damage by activating mononuclear phagocytes (microglia) that accumulate in and around senile plaques. In this study, we show that the 42 amino acid form of beta amyloid peptide, Abeta(42), is a chemotactic agonist for a seven-transmembrane, G-protein-coupled receptor named FPR-Like-1 (FPRL1), which is expressed on human mononuclear phagocytes. Moreover, FPRL1 is expressed at high levels by inflammatory cells infiltrating senile plaques in brain tissues from AD patients. Thus, FPRL1 may mediate inflammation seen in AD and is a potential target for developing therapeutic agents.
33
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
Shi Du Yan, Xi Chen, Jin Fu et al. · Nature · 1996 · 2K citations
β-Amyloid-mediated vasoactivity and vascular endothelial damage
Tom Thomas, George Thomas, Chris McLendon et al. · Nature · 1996 · 699 citations
Shi Du Yan, Huaijie Zhu, Jin Fu et al. · Proceedings of the National Academy of Sciences · 1997 · 437 citations · Full text